Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Tobias Mattsson new CEO of Rapunzel of Sweden

Tobias Mattsson will take over as the new CEO of Rapunzel of Sweden, effective October 1, 2018. He comes most recently from his role as the CEO of the e-commerce company NordicFeel."With Tobias Mattsson's extensive international experience in managing and developing e-commerce companies, Rapunzel of Sweden is now securing the additional competence to continue developing the company as a leading player in hair extensions and related services and products as an international brand," says Arthur Engel, Chair of the Board of Directors for Rapunzel of Sweden. Tobias Mattsson comes most

First Canadian patent approval for Episurf Medical

Episurf Medical (NASDAQ: EPIS B) has received its first Notice of Allowance from the The Canadian Intellectual Property Office (CIPO). The patent, entitled “Surgical kit for cartilage repair comprising implant and a set of tools”, has a focus on the company’s individualised Episealer® Femoral Twin joint implant and its design. "The first approval in a for us new country is an important step. We are looking forward to future activities in North America”, comments Pål Ryfors, CEO, Episurf Medical. For more  information, please contact: Pål Ryfors, CEO, Episurf Medical Tel:+46 (

Successful crowd funding by FarmPharma via FundedByMe

On June 20 this year, FarmPharma AB started a crowd funding campaign to bring together funding for the company's further development. Today, 100% of the minimum target has been achieved and more than 50 investors have chosen to invest their money in FarmPharma's future. The campaign ends at 23:59 on 18/9 2018, or when the maximum funding target is reached. "We are very pleased that FarmPharma has attracted so much interest among investors," commented Igor Lokot, CEO of Double Bond Pharmaceutical and FarmPharma, but it is still about 20 days left of the campaign and now we are working

SenzaGen targets the growing medical device market

Lund, August 29, 2018 - SenzaGen (Nasdaq First North: SENZA) announces today that the Company is now expanding its market focus to the medical device market. This market is in strong growth as a result of a growing and aging population in combination with a new regulatory framework for medical devices and increased quality standards.Today, SenzaGen focuses on the chemicals, cosmetics and pharmaceutical markets for its global commercialization of GARD®, an in vitro platform for risk assessment of chemicals. Now, the Company has decided to further expand its market presence and will also

Targovax ASA: Settlement of restricted stock units and resolution to increase the share capital

In connection with the publication of the Q2 2018 quarterly financial report, Targovax ASA (the "Company") has completed a settlement period for vested restricted stock units ("RSUs"). The settlement period commenced on 24 August 2018 at 10:00 hours (CET) and ended on 28 August 2018 at 10:00 hours (CET). 1. Settlement of RSUs In total were 6,581 shares, each with a par value of NOK 0.10, subscribed for following settlement of RSUs. 2. Resolution to increase the share capital in Targovax ASA  In order to facilitate the settlement of RSUs, the Company's board of directors has on

Lund University research group receives follow-on DKK 1 million grant from Novo Nordisk Foundation for diabetes-related studies with Follicum peptides

Follicum AB ("Follicum") today announced that Professor Jan Nilsson's research team at Lund University has received an additional DKK 1,000,000 funding from the Novo Nordisk Foundation for carrying out preclinical studies for Follicum’s diabetes project based on modified osteopontin-related peptides. This represents a follow-on grant from the estimated DKK 400,000 the group received in 2017. Follicum owns the right to the results generated in connection with the project.The Novo Nordisk Foundation mainly supports research within e.g. biomedicine, biotechnology, general medicine and nursing

CombiGene´s research attracts international attention

CombiGene´s research on the antiepileptic properties of neuropeptide Y and the Y2 receptor attracts international attention. Today, August 29th, 2018, the PhD student Esbjörn Melin will present the results of the preclinical long-term study conducted by CombiGene together with Professor Mérab Kokaia and his team at the Epilepsy Center in Lund. The oral presentation will take place at the 13th European Congress on Epileptology in Vienna, Austria. The team at CombiGene wishes Esbjörn all the best with his presentation at this important congress!

Peab announces Chief Communications Officer

Camila Buzaglo will take on the role of CCO at Peab during the autumn of 2018.Camila Buzaglo will become a member of executive management which will then consist of: Jesper Göransson, President and CEONiclas Winkvist, CFORoger Linnér, COOCamila Buzaglo, CCOStefan Danielsson, Business Area Construction ManagerKG Karlsson, Business Areas Civil Engineering and Industry ManagerGöran Linder, Business Area Project Development Manager Camila Buzaglo comes to Peab from her position as CCO at IP-Only. She has previously worked with communication and community contacts at Telia.

Enzymatica AB: Appeal of court ruling on Enzymatica's cold spray in Germany

Press release August 29, 2018 Appeal of court ruling on Enzymatica's cold spray in Germany Enzymatica's distributor in Germany has appealed to the regional court of Frankfurt on their decision to put restrictions on the marketing of the mouth spray ViruProtect® in Germany. In the meantime the distributor will not place any further orders to Enzymatica of ViruProtect. Enzymatica's ColdZyme® Mouth Spray is sold under the brand name ViruProtect in Germany, Belgium and Austria. On July 16[th] Enzymatica announced that the regional court of Frankfurt put restrictions of the marketing

Interim Report Second Quarter 2018

As of August 29, 2018 at 08.00, the company’s interim report for the second quarter of 2018 is available on https://diamorph.com/investor/. For additional information, please contact: Gordon MacLeman, CEOTelephone: +44 161 955 2410 Mark Hutchison, CFOTelephone: +44 161 955 2409 The information was submitted for publication on August 29, 2018, at 08:00. Diamorph supplies advanced material solutions for especially demanding industrial applications. The Company is headquartered in Stockholm and has subsidiaries in the United Kingdom and the Czech Republic. Learn more at www.

Kraken FPSO settlement agreement

EnQuest PLC, 29 August 2018 Kraken FPSO settlement agreement EnQuest PLC ('EnQuest'), an independent oil and gas production and development company listed on the London and Stockholm stock exchanges (ENQ.L and ENQ.ST), is pleased to announce an agreed compensation settlement with Armada Kraken Pte Ltd, a wholly-owned subsidiary of Bumi Armada Berhad ('Bumi'), in relation to historic issues with the FPSO. Bumi has agreed to pay $15 million to the Kraken partners, which is to be fully settled by 17 December 2018. While there is still further work to complete before a final acceptance

Apta-1 has in the ongoing toxicology program indicated a good safety profile that resulted in a greater substance need, which delays the program

Aptahem AB (publ) announce today that the company's ongoing pre-clinical toxicology development program is delayed pending the manufacturing of more Apta-1. The drug candidate Apta-1 has in the company's ongoing toxicology program indicated a good safety profile, which has resulted in a greater substance need (Apta-1) than expected. The results also indicate that the dosages can be increased in the ongoing efficacy study in NHP (Non Human Primate), which warrant us to test higher dosages and lead to an extension of the study. The time required for the manufacturing of new substance causes

H&M Foundation puts €1M and coaching program on the table for ideas reinventing the entire fashion industry – special call for digital innovation

Today, the non-profit H&M Foundation opens the fourth round of its annual innovation challenge Global Change Award at globalchangeaward.com . With over 8,000 entries from 151 countries since 2015, it’s the go-to competition for circular innovation and has been named the Nobel Prize of fashion. It provides powerful funding and yearlong coaching to innovators who come up with solutions to spark the shift towards a circular fashion industry, protecting the planet and our living conditions. This year there’s an extra eye on ideas within

AcadeMedia’s Year-end Report 2017/18

Fourth quarter (April – June 2018) · Net sales increased by 14.7 percent to SEK 2,993 million (2,610). Organic growth including bolt-on acquisitions amounted to 4.1 percent. · Operating profit (EBIT) declined by 20.9 percent to SEK 167 million (211). Adjusted for items affecting comparability, operating profit was SEK 207 million (229). · Net profit was SEK 111 million (154) in the period. · Cash flow from operating activities amounted to SEK 376 million (317). · The average number of children and students in pre-, compulsory, and upper secondary schools during the fourth

Changes in Fortum Executive Management – Head of Solar & Wind Development and M&A to leave Fortum

FORTUM CORPORATION STOCK EXCHANGE RELEASE 29 AUGUST 2018 AT 9.00 EEST   Mr Kari Kautinen, Senior Vice President, Solar & Wind Development and M&A has decided to leave Fortum. It has been mutually agreed that Mr Kautinen will continue his duties until the end of September 2018. Mr Kautinen joined Fortum in 1998 and has been a member of the Fortum Executive Management since 2014. Prior to his current role he was in charge of Fortum’s Strategy as well as Mergers and Acquisitions in the management team. Replacement arrangements have been initiated. “Kari has played a central role in

Eastnine AB publishes Interim report for the second quarter 2018

Key events during the quarter: · Net Asset Value (NAV) per share was SEK 109.5, or EUR 10.48, a decrease of 1.5% during the quarter¹. · Core segment Real Estate Direct increased in value by 2.2% and Real Estate Funds by 2.1%, while Other decreased by 3.0% due to currency translation of MFG as a result of weaker RUB. · Divestment of the remaining holding in EC Global Frontier Markets Fund for EUR 3.7m. · The AGM approved an ordinary dividend of SEK 2.10 per share with semi-annual payments of SEK 1.05 each, and a long-term share-based incentive plan for staff. · Johan

Jussi Rouhento new Managing Director at Catella Asset Management Finland

Jussi Rouhento has been appointed Managing Director at Catella Asset Management Finland. He will start his position on January 2, 2019 and will replace Eero Syväniemi who retires in February 2019.Jussi Rouhento has been head of Northern Horizon Capital’s Finnish business and Fund Manager of their Healthcare funds. Rouhento has long and extensive experience in property fund and asset management operations in both Finland and Nordics. He will further strengthen Catella’s position in the Finnish and Nordic property fund and asset management operations. ”We are delighted to welcome Jussi

Tele2 AB: Nomination Committee’s proposals regarding election of Board of Directors

In advance of Tele2 AB’s (Tele2) (NASDAQ Stockholm Exchange: TEL2 A and TEL2 B) Extraordinary General Meeting of shareholders, to be held on 21 September 2018, that will resolve on the proposed merger between Tele2 and Com Hem Holding AB (Com Hem), the Tele2 Nomination Committee proposes the election of current Com Hem Board Directors Andrew Barron and Eva Lindqvist as new Directors of the Board once the merger of Tele2 and Com Hem has been registered with the Swedish Companies Registration Office. The Nomination Committee also proposes the election of Lars-Åke Norling as a new Director of

NOTICE TO ATTEND THE EXTRAORDINARY GENERAL MEETING

The shareholders of Tele2 AB (publ) are hereby invited to the Extraordinary General Meeting on Friday September 21, 2018, at 13.00 CEST at Fotografiska Event & Konferens, Stadsgårdshamnen 22 in Stockholm, Sweden.NOTICE ETC. Shareholders who wish to attend the Extraordinary General Meeting shall · be entered in the share register maintained by Euroclear Sweden AB on Friday September 14, 2018, and · give notice of their intention to attend no later than Monday September 17, 2018. Notice to attend is to be made on the company’s website at www.tele2.com under the heading “

Sale of shares in Catena Media plc

Press release, 29 August 2018 NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES, CANADA, JAPAN OR AUSTRALIA OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. Optimizer Invest Ltd (the “Seller”), have sold 4,350,000 shares in Catena Media plc (“Catena Media”) through an accelerated bookbuilding to Swedish and international institutional investors at a price of SEK 106.50 per share (the “Placing”). Following the Placing, the Seller will own 2,924,412 shares, corresponding to approximately 5.2 % of

Tele2 announces Leadership Team positions in merged company

NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, HONG KONG, JAPAN, CANADA OR SOUTH AFRICA OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. OTHER RESTRICTIONS ARE APPLICABLE. PLEASE SEE THE IMPORTANT NOTICE AT THE END OF THE PRESS RELEASE. Stockholm – Tele2 AB, (Tele2), (NASDAQ OMX Stockholm: TEL2 A and TEL2 B) today announces a number of Leadership Team (LT) positions in the merged company of Tele2 and Com Hem. Additional LT positions will be announced before the closing of the merger. In January 2018, Tele2 and Com Hem

Flexion Mobile Plc - Q1 Report 30 June 2018

Flexion sees very strong first quarter growthApr18 – Jun18 Q1 financial performance · IAP (In App Purchase) revenue increased by 371% to GBP 993,245 (GBP 210,926*) · Total revenue increased by 173% to GBP 1,038,408 (GBP 380,776) · Gross profit increased by 105% to GBP 239,532 (GBP 116,706) · EBITDA fell by 25% to GBP -440,761 (GBP -351,826) · Loss per share increased to -0.73 pence (-0.52 pence) · Operating cash flow fell by 12% to GBP -172,712 (GBP -154,683)  · Cash amounted to GBP 7.4m (GBP 2.0m) * Comparable number for the first quarter of the previous financial

Electrolux showcases innovative home solutions at IFA 2018

Electrolux demonstrates the latest innovations within the home at IFA 2018, one of the world’s biggest fairs within consumer electronics taking place in Berlin, Germany on August 31 to September 5. Electrolux will highlight new smart solutions within the kitchen, laundry and floor care, designed to enhance the consumer experience.Under the core brand AEG, will Electrolux highlight the ultimate in food preparation with a new range of induction hobs that provides precise and automated assistance when cooking, to connected steam ovens with intuitive levels of steam cooking. New intelligent

Tele2 publishes merger document for the Com Hem merger

NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, HONG KONG, JAPAN, CANADA OR SOUTH AFRICA OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. OTHER RESTRICTIONS ARE APPLICABLE. PLEASE SEE THE IMPORTANT NOTICE AT THE END OF THE PRESS RELEASE. Tele2 (Tele2) (NASDAQ Stockholm Exchange: TEL2 A and TEL2 B) today publishes the merger document relating to the merger with Com Hem, which has been approved and registered by the Swedish Financial Supervisory Authority. Separately, Tele2 publishes a notice to attend an Extraordinary General

There are no items matching the current filter
There are no more items matching the current filter
Back to top